ISPD CARDIOVASCULAR AND METABOLIC GUIDELINES IN ADULT PERITONEAL DIALYSIS PATIENTS PART I - ASSESSMENT AND MANAGEMENT OF VARIOUS CARDIOVASCULAR RISK FACTORS

被引:92
作者
Wang, Angela Yee Moon [1 ]
Brimble, K. Scott [2 ]
Brunier, Gillian [3 ]
Holt, Stephen G. [4 ]
Jha, Vivekanand [5 ]
Johnson, David W. [6 ,7 ]
Kang, Shin-Wook [8 ]
Kooman, Jeroen P. [9 ]
Lambie, Mark [10 ]
McIntyre, Chris [11 ]
Mehrotra, Rajnish [12 ]
Pecoits-Filho, Roberto [13 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada
[3] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada
[4] Univ Melbourne, Royal Melbourne Hosp, Div Nephrol, Melbourne, Vic 3050, Australia
[5] George Inst Global Hlth India, Postgrad Inst Med Educ & Res, Chandigarh, India
[6] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia
[7] Translat Res Inst, Ctr Kidney Dis Res, Brisbane, Qld, Australia
[8] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Dept Internal Med, Seoul 120749, South Korea
[9] Univ Hosp Maastricht, Div Nephrol, Maastricht, Netherlands
[10] Keele Univ, Inst Sci & Technol Med, Hlth Serv Res Unit, Keele ST5 5BG, Staffs, England
[11] Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Derby, England
[12] Univ Washington, Harborview Med Ctr, Dept Med, Div Nephrol, Washington, DC USA
[13] Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2015年 / 35卷 / 04期
关键词
Cardiovascular risk; residual renal function; volume; salt; glycosylated hemoglobin; hypertension; dyslipidemia; anemia; inflammation; obesity; hypokalemia; dialysate calcium; peritoneal dialysis; RESIDUAL RENAL-FUNCTION; CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; HEMODIALYSIS-PATIENTS; PHYSICAL-EXERCISE; FLUID MANAGEMENT; VOLUME OVERLOAD; BLOOD-PRESSURE; MORTALITY; HYPERTENSION;
D O I
10.3747/pdi.2014.00279
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease contributes significantly to the adverse clinical outcomes of peritoneal dialysis (PD) patients. Numerous cardiovascular risk factors play important roles in the development of various cardiovascular complications. Of these, loss of residual renal function is regarded as one of the key cardiovascular risk factors and is associated with an increased mortality and cardiovascular death. It is also recognized that PD solutions may incur significant adverse metabolic effects in PD patients. The International Society for Peritoneal Dialysis (ISPD) commissioned a global workgroup in 2012 to formulate a series of recommendations regarding lifestyle modification, assessment and management of various cardiovascular risk factors, as well as management of the various cardiovascular complications including coronary artery disease, heart failure, arrhythmia (specifically atrial fibrillation), cerebrovascular disease, peripheral arterial disease and sudden cardiac death, to be published in 2 guideline documents. This publication forms the first part of the guideline documents and includes recommendations on assessment and management of various cardiovascular risk factors. The documents are intended to serve as a global clinical practice guideline for clinicians who look after PD patients. The ISPD workgroup also identifies areas where evidence is lacking and further research is needed.
引用
收藏
页码:379 / 387
页数:9
相关论文
共 50 条
  • [1] Cystatin C Levels in Functionally Anephric Patients Undergoing Dialysis: The Effect of Different Methods and Intensities
    Al-Malki, Najila
    Heidenheim, Paul A.
    Filler, Guido
    Yasin, Abeer
    Lindsay, Robert M.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (10): : 1606 - 1610
  • [2] Standards of Medical Care in Diabetes-2014
    不详
    [J]. DIABETES CARE, 2014, 37 : S14 - S80
  • [3] Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc11-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc12-s011, 10.2337/dc10-S011, 10.2337/dc10-S062, 10.2337/dc13-S011, 10.2337/dc12-s064]
  • [4] [Anonymous], 2013, KIDNEY INT S, pS73
  • [5] Effect of fluid and sodium removal on mortality in peritoneal dialysis patients
    Ates, K
    Nergizoglu, G
    Keven, K
    Sen, A
    Kutlay, S
    Ertürk, S
    Duman, N
    Karatan, O
    Ertug, AE
    [J]. KIDNEY INTERNATIONAL, 2001, 60 (02) : 767 - 776
  • [6] Braatvedt G, 2006, NZ MED J, V119, P1
  • [7] Survival of functionally anuric patients on automated peritoneal dialysis: The European APD Outcome Study
    Brown, EA
    Davies, SJ
    Rutherford, P
    Meeus, F
    Borras, M
    Riegel, W
    Divino, JC
    Vonesh, E
    Van Bree, M
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (11): : 2948 - 2957
  • [8] Effect of inhibitors of the renin-angiotensin system and other anti hypertensive drugs on renal outcomes: systematic review and meta-analysis
    Casas, JP
    Chua, WL
    Loukogeorgakis, S
    Vallance, P
    Smeeth, L
    Hingorani, AD
    MacAllister, RJ
    [J]. LANCET, 2005, 366 (9502) : 2026 - 2033
  • [9] Does periodontal disease reflect atherosclerosis in continuous ambulatory peritoneal dialysis patients?
    Cengiz, M. Inanc
    Bal, Seda
    Goekcay, Sibel
    Cengiz, Kuddusi
    [J]. JOURNAL OF PERIODONTOLOGY, 2007, 78 (10) : 1926 - 1934
  • [10] Biocompatible dialysis fluids for peritoneal dialysis
    Cho, Y.
    Johnson, D. W.
    Craig, J. C.
    Strippoli, G. F. M.
    Badve, S., V
    Wiggins, K. J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03):